liraglutide

Generic: liraglutide

Labeler: hikma pharmaceuticals usa inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name liraglutide
Generic Name liraglutide
Labeler hikma pharmaceuticals usa inc.
Dosage Form INJECTION
Routes
SUBCUTANEOUS
Active Ingredients

liraglutide 6 mg/mL

Manufacturer
Hikma Pharmaceuticals USA Inc.

Identifiers & Regulatory

Product NDC 0143-9144
Product ID 0143-9144_f242c0f8-6d4f-4a78-a1fd-433a0672dbd3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA215503
Listing Expiration 2026-12-31
Marketing Start 2024-12-24

Pharmacologic Class

Established (EPC)
glp-1 receptor agonist [epc]
Mechanism of Action
glucagon-like peptide-1 (glp-1) agonists [moa]
Chemical Structure
glucagon-like peptide 1 [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01439144
Hyphenated Format 0143-9144

Supplemental Identifiers

RxCUI
897122
UNII
839I73S42A
NUI
N0000178480 M0160181 N0000020058

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name liraglutide (source: ndc)
Generic Name liraglutide (source: ndc)
Application Number ANDA215503 (source: ndc)
Routes
SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 6 mg/mL
source: ndc
Packaging
  • 2 SYRINGE, PLASTIC in 1 CARTON (0143-9144-02) / 3 mL in 1 SYRINGE, PLASTIC
  • 3 SYRINGE, PLASTIC in 1 CARTON (0143-9144-03) / 3 mL in 1 SYRINGE, PLASTIC
source: ndc

Packages (2)

Ingredients (1)

liraglutide (6 mg/mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["SUBCUTANEOUS"], "spl_id": "f242c0f8-6d4f-4a78-a1fd-433a0672dbd3", "openfda": {"nui": ["N0000178480", "M0160181", "N0000020058"], "unii": ["839I73S42A"], "rxcui": ["897122"], "spl_set_id": ["2100ec49-57b2-4330-ab5f-057ce9b7e4d0"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "manufacturer_name": ["Hikma Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 SYRINGE, PLASTIC in 1 CARTON (0143-9144-02)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0143-9144-02", "marketing_start_date": "20241224"}, {"sample": false, "description": "3 SYRINGE, PLASTIC in 1 CARTON (0143-9144-03)  / 3 mL in 1 SYRINGE, PLASTIC", "package_ndc": "0143-9144-03", "marketing_start_date": "20241224"}], "brand_name": "Liraglutide", "product_id": "0143-9144_f242c0f8-6d4f-4a78-a1fd-433a0672dbd3", "dosage_form": "INJECTION", "pharm_class": ["GLP-1 Receptor Agonist [EPC]", "Glucagon-Like Peptide 1 [CS]", "Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "product_ndc": "0143-9144", "generic_name": "liraglutide", "labeler_name": "Hikma Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Liraglutide", "active_ingredients": [{"name": "LIRAGLUTIDE", "strength": "6 mg/mL"}], "application_number": "ANDA215503", "marketing_category": "ANDA", "marketing_start_date": "20241224", "listing_expiration_date": "20261231"}